Goldman Sachs
NUVA

Goldman Sachs’s NuVasive, Inc. NUVA Stock Holding History

Goldman Sachs’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-961,190
Closed -$40M – 6014
2023
Q2 		$40M Sell
961,190
-247,193
-20% -$10.1M 0.01% 1269
2023
Q1 		$49.9M Buy
1,208,383
+463,286
+62% +$19.8M 0.01% 1078
2022
Q4 		$30.7M Buy
745,097
+107,423
+17% +$4.35M 0.01% 1574
2022
Q3 		$27.9M Buy
637,674
+74,785
+13% +$3.62M 0.01% 1571
2022
Q2 		$27.7M Sell
562,889
-486,657
-46% -$26.1M 0.01% 1626
2022
Q1 		$59.5M Buy
1,049,546
+192,295
+22% +$10.2M 0.01% 1142
2021
Q4 		$45M Sell
857,251
-61,370
-7% -$3.34M 0.01% 1423
2021
Q3 		$55M Buy
918,621
+13,715
+2% +$846K 0.01% 1213
2021
Q2 		$61.3M Buy
904,906
+408,308
+82% +$27.9M 0.01% 1095
2021
Q1 		$32.6M Sell
496,598
-98,786
-17% -$5.93M 0.01% 1518
2020
Q4 		$33.5M Sell
595,384
-127,621
-18% -$6.28M 0.01% 1445
2020
Q3 		$35.1M Sell
723,005
-873,272
-55% -$47.1M 0.01% 1281
2020
Q2 		$88.8M Sell
1,596,277
-356,220
-18% -$20.6M 0.03% 597
2020
Q1 		$98.9M Buy
1,952,497
+268,462
+16% +$18M 0.03% 520
2019
Q4 		$130M Sell
1,684,035
-33,053
-2% -$2.33M 0.03% 574
2019
Q3 		$109M Buy
1,717,088
+432,163
+34% +$27M 0.03% 607
2019
Q2 		$75.2M Sell
1,284,925
-356,156
-22% -$21M 0.02% 858
2019
Q1 		$93.2M Buy
1,641,081
+576,277
+54% +$30.6M 0.03% 708
2018
Q4 		$52.8M Sell
1,064,804
-469,196
-31% -$28.2M 0.02% 1050
2018
Q3 		$109M Sell
1,534,000
-249,140
-14% -$15.9M 0.03% 704
2018
Q2 		$92.9M Sell
1,783,140
-2,955
-0.2% -$155K 0.03% 795
2018
Q1 		$93.3M Buy
1,786,095
+129,469
+8% +$6.57M 0.02% 815
2017
Q4 		$96.9M Sell
1,656,626
-155,653
-9% -$8.83M 0.02% 811
2017
Q3 		$101M Sell
1,812,279
-341,496
-16% -$22.6M 0.02% 805
2017
Q2 		$166M Buy
2,153,775
+1,554,224
+259% +$116M 0.04% 496
2017
Q1 		$44.8M Sell
599,551
-814,473
-58% -$59.1M 0.01% 1295
2016
Q4 		$95.2M Sell
1,414,024
-87,666
-6% -$5.65M 0.03% 807
2016
Q3 		$100M Sell
1,501,690
-126,899
-8% -$8.08M 0.03% 718
2016
Q2 		$97.3M Buy
1,628,589
+1,174,296
+258% +$63.5M 0.03% 688
2016
Q1 		$22.1M Sell
454,293
-31,894
-7% -$1.45M 0.01% 1654
2015
Q4 		$26.3M Sell
486,187
-33,952
-7% -$1.73M 0.01% 1558
2015
Q3 		$25.1M Sell
520,139
-83,347
-14% -$4.31M 0.01% 1553
2015
Q2 		$28.6M Buy
603,486
+44,796
+8% +$2.09M 0.01% 1542
2015
Q1 		$25.7M Sell
558,690
-121,524
-18% -$5.65M 0.01% 1579
2014
Q4 		$32.1M Buy
680,214
+1,105
+0.2% +$46.1K 0.01% 1467
2014
Q3 		$23.7M Buy
679,109
+82,194
+14% +$2.93M 0.01% 1672
2014
Q2 		$21.2M Buy
596,915
+221,400
+59% +$7.58M 0.01% 1743
2014
Q1 		$14.4M Sell
375,515
-197,770
-34% -$7.27M ﹤0.01% 2049
2013
Q4 		$18.5M Buy
573,285
+151,776
+36% +$4.56M 0.01% 1804
2013
Q3 		$10.3M Buy
421,509
+64,654
+18% +$1.59M ﹤0.01% 2214
2013
Q2 		$8.85M Buy
+356,855
New +$7.81M ﹤0.01% 2201

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Goldman Sachs's NUVA Position: Q3 2023 in Review

Goldman Sachs sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 961,190 shares — an estimated $40M sold.

Goldman Sachs first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $166M in Q2 2017. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Goldman Sachs reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 961,190 NuVasive, Inc. shares in Q3 2023, an estimated $40M.
  • Goldman Sachs first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Goldman Sachs's NuVasive, Inc. position peaked at $166M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.